Walleye Trading
ENTA icon

Walleye Trading’s Enanta Pharmaceuticals ENTA Stock Holding History

Walleye Trading’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,700
Closed -$353K – 4143
2019
Q1 		$353K Buy
3,700
+2,200
+147% +$197K ﹤0.01% 2554
2018
Q4 		$106K Buy
+1,500
New +$115K ﹤0.01% 3862

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Walleye Trading's ENTA Position: Q2 2019 in Review

Walleye Trading sold out of Enanta Pharmaceuticals (ENTA) in Q2 2019, closing a stake of 1,688 shares — an estimated $161K sold.

Walleye Trading first reported a position in ENTA in Q3 2015 and held it in 4 quarters. The position peaked at $318K in Q4 2016. 194 funds tracked by Wall St. Rank hold ENTA as of Q2 2019.

  • Walleye Trading reported no remaining Enanta Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Walleye Trading sold 1,688 Enanta Pharmaceuticals shares in Q2 2019, an estimated $161K.
  • Walleye Trading first reported a position in Enanta Pharmaceuticals in Q3 2015 and held it in 4 quarters.
  • Walleye Trading's Enanta Pharmaceuticals position peaked at $318K in Q4 2016.
  • 194 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2019.

Based on Walleye Trading's 13F filing for Q2 2019, filed 14 Aug 2019.